Dr. Jay Duker examines the critical issue of OCT artifacts and discusses how to identify and remedy them. NOTE: This movie is based on a live lecture and contains a few minor audio defects- they're not significant enough to interfere with your viewing experience and should not be confused with any problems with your viewing system. Dr. Duker's Financial Interest Disclosure: Stockholder- Hemera Biosciences Research Support- OptoVue Carl Zeiss Meditech Topcon Scientific Advisory Board- Paloma Pharmaceuticals Consultant- Alcon Genentech Ophthotech Novartis Neovista.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…